Chen, Xiangpeng http://orcid.org/0000-0001-6955-6515
Zhang, Yong
Mao, Naiying
Zhu, Shuangli
Ji, Tianjiao
Xu, Wenbo
Funding for this research was provided by:
National Science and Technology Major Project of the Ministry of Science and Technology of China (2018ZX10201002-003-009, 2017ZX10104001-005-010, 2018ZX10713002, 2018ZX10713001-003)
Beijing Natural Science Foundation (7184208)
Basic and Clinical Research Cooperation Project of Capital Medical University (17JL11)
Research Training Fund of Capital Medical University (PYZ2017012)
Article History
Received: 13 March 2019
Accepted: 26 August 2019
First Online: 30 September 2019
Compliance with ethical standards
:
: The authors have no conflicts of interest to declare.
: The program for immunization with CV-A16 VLPs or inactivated CV-A16 combined with CpG ODN was approved by the Ethical Committee of the National Institute of Viral Disease Control and Prevention, China CDC. The animal care and use protocol in this study abided by “The Guidance on Treating Experimental Animals”, which was promulgated by the Ministry of Science and Technology of China. No nonhuman primates were used in this study.
Free to read: This content has been made available to all.